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Cisplatin (cDDP) is a commonly used anticancer agent for treat-
ment of a variety of different malignancies. It is thought to act by
forming adducts with cellular DNA, which leads to inhibition of
DNA replication (Pinto and Lippard, 1985) RNA transcription
(Corda et al, 1991), as well as activation of the cellular injury
response (CIR) (Howell et al, 1996). The latter requires a system
for detection of DNA damage (Toney et al, 1989), assessment of
the extent of the damage (Eastman, 1990) and finally a system to
initiate either repair or apoptosis (Eastman, 1990). Each phase in
this process from damage recognition to repair or apoptosis needs
the participation of a large number of gene products. Therefore, it
seems reasonable to assume that the cDDP-induced CIR can be
characterized by the sum of changes in expression level of many
specific genes (Howell et al, 1996). In view of the fact that little is
known about the specific pathways activated by cDDP-induced
CIR, the main goal of this study is to identify genes whose expres-
sion level is altered after exposure to cDDP and to classify these
genes according to their function. For this purpose we combined
the suppression subtractive hybridization technique (Diatchenko
et al, 1996) with a custom array technology, which has been
recently reported to be productive in identifying differentially
expressed genes in other model systems as well (Kuang et al,
1998; Johnsson et al, 2000). 
MATERIAL AND METHODS 
Cells 
UMSCC10b human squamous cell carcinoma cells (Grenman 
et al, 1991) were cultured in RPMI 1640 (Irvine Scientific, Santa
Ana, CA) supplemented with 2 mM L-glutamine, 100 units ml–1 of
penicillin G, 100 mg ml–1 of streptomycin sulfate and 10% fetal
bovine serum (Gibco BRL, Grand Island, NY). 
mRNA extraction 
The mRNA used for library construction was isolated from 80%
confluent cells by acid guanidium phenol-chloroform extraction
followed by isolation of poly(A)+ mRNA using the Oligotex
mRNA Midi Kit (Qiagen Inc, Chatsworth, CA). The mRNA used
to make cDNA-probes directly from tumour cells was isolated by
using the mRNA Direct Kit (Qiagen). 
Suppression subtractive hybridization 
SSH was performed using the ClonTech PCR-select cDNA
Subtraction kit (Clontech Laboratories Inc, Palo Alto, CA)
according to the manufacturer’s instructions and as described in
detail by Johnsson et al (2000). 
Preparation of membrane arrays 
PCR amplified cDNA fragment from the bacterial clones were
spotted onto Magna Graph nylon membranes (Micron Separation
Inc, Westborough, MA). Each membrane consisted of a maximum
of 108 spots. Water, β -actin, adaptor sequences corresponding to
the nested primers and serial dilutions of the whole population of
cDNA fragments recovered from forward or reverse SSH steps
were included as internal controls (Johnsson et al, 2000). 
Membrane hybridizations 
Two types of hybridization probes were used in this study. The
first was a PCR-amplified probe, containing cDNA fragments
recovered from either the forward or reversed SSH step and which
putatively contained only cDNA fragments corresponding to
differentially expressed mRNAs (Diatchenko et al, 1996; Johnsson
et al, 2000). The second probe was used to perform reversed
Northern hybridizations. It consisted of cDNA from cDDP-treated
and -untreated UMSCC10b cells, prepared by reverse transcrip-
tion of total cellular mRNA. All probes were labelled with 32P by
utilizing the Multiprime Labeling Kit (Amersham Life Science,
Arlington Heights, IL), with 20 ng of cDNA per probe (specific
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activity ranged from 5 × 107 to 8 × 108 cpm µ g–1 DNA). Using
these probes (5 ng ml–1) membranes were hybridized for 16 h at
68˚C. Hybridizations with subtracted SSH-derived PCR-amplified
probes (screening) were performed in triplicate and hybridization
with cDNA non-amplified cDNA probes (reversed northerns)
were performed in duplicate, triplicate or quadruplet. Analysis of
the hybridization was performed with an imaging system from
Bio-Rad Laboratories, Hercules, CA and the data were analysed
with the PC-based Molecular Analyst Software. 
Sequencing and identification of identified fragments 
Plasmids containing cDNA fragments that were differentially
expressed were sequenced using either primers homologous to the
M13 reversed priming site of the plasmid, or nested primers
targeted to adaptors 1 or 2R. The sequencing was performed with
a 373 XL Automated DNA Sequencer (Perkin-Elmer/Applied
Biosystems, Norwalk, CT) at the UCSD Core Facility. 
RESULTS AND DISCUSSION 
Library construction and differential screening 
SSH was used to create a population of cDNA fragments corre-
sponding to mRNAs whose levels were either increased (the UP
library) or decreased (the DOWN library, created by the reversed
subtraction using the non-treated cells as tester) in the UMSCC10b
cells exposed to an IC99 concentration (50 µ M) of cDDP relative to
the untreated UMSCC10b cells. Figure 1 presents a flow diagram
of the yield from each step of the isolation procedure. 
The PCR products generated from the bacterial inserts were
screened for differential expression with PCR-amplified SSH
probes on membrane arrays (Diatchenko et al, 1996; Johnsson 
et al, 2000). Array elements demonstrating >5-fold differences in
abundance in the UP and DOWN subtracted libaries in at least 1 of
3 repeat hybridizations were selected for further investigation.
Based on this criterion, 26 (13%) and 44 (29%) fragments were
identified as being differentially expressed in the UP and DOWN
library, respectively. Although modest, these percentages are of
the same order of magnitude as demonstrated in a recent study
from this laboratory (Johnsson et al, 2000). 
Magnitude of differential expression determined by
reversed Northern blot analysis 
The magnitude of the difference in abundance between the mRNA
levels in the cDDP-exposed and non-exposed UMSCC10b cells
were examined further by reversed Northern blotting. 70 cDNAs
present in the UP (26) and DOWN (44) libraries were spotted onto
membrane arrays and hybridized with cDNA probes prepared
from mRNA of cells exposed and non-exposed to cDDP (IC99).
Hybridizations were repeated 2 to 4 times and the mean level of
differential expression for each element in the array was calculated
as the ratio between cDDP-exposed and -non-exposed cells. Of the
26 cDNAs present in the UP library, 16 (62%) corresponded to
mRNAs that demonstrated at least a 1.6-fold difference in level.
Among these 16 cDNAs 4 showed at least a 4-fold difference and
1 at least a 10-fold difference (Table 1). Of the 44 cDNAs in the
DOWN library, 30 (68%) demonstrated at least a 1.6-fold differ-
ence in expression. Among these 6 cDNAs showed at least a 
4-fold difference. None had a 10-fold difference (Table 2). The
finding that the majority of mRNAs show little change, and a
progressively smaller fraction shows incrementally larger changes
is consistent with results obtained in other systems where either
isogenic cells growing under different conditions have been
compared (Zhang et al, 1997) or in a steady state condition where
tumour cells resistant to cDDP were compared to their sensitive
variant (Johnsson et al, 2000). 
Validation of the magnitude of expressing was obtained using 1
or 2 fragments in each library present multiple times. In the
DOWN library β -actin and α -tubulin were identified 4 and 3
times, respectively. The mean expression of their expression ratios
was 3.4 ± 1.5 and 2.9 ± 0.9, respectively. In the UP library MDM2
was present in 4 different bacterial clones, resulting in expression
levels 1.9 ± 0.1. Overall, the mean variance is small and confirms
previous observations of biological variation between samples
(Zhang et al, 1997; Johnsson et al, 2000). 
Identification of cDNA fragments 
The cDNA fragments corresponding to the 16 mRNAs in the UP
library and 30 mRNAs in the DOWN library that demonstrated at
least a 1.6-fold increase or decrease in expression were sequenced.
43 (92%) of these were identifiable as segments of cDNAs
contained in GenBank, 1 (2%) was an EST and 3 (6%) were
unknown. Some genes were identified more than once. mRNA
encoding mitochondrial genes and MDM2 were identified
multiple times in the UP library, and β -actin, and α -tubulin were
found more than once in the DOWN library. In the UP library 2
clusters of genes can be identified (Table 1). The first cluster
consists of mitochondrial related genes, the 16S rRNAs and
BC200. The human mtDNA encoding rRNAs (rRNAs 12 S and
16S rRNA) are involved in the synthesis of several subunits of
cDDP-treated
UMSCC10b cells
Un- treated
UMSCC10b cells
Subtractive Suppression Hybridization
PCR Verification
Differential screening using subtracted probes (SSH probes)
Reversed Northern hybridizations
Sequencing of truly differential expressed fragments
UP library DOWN library
No. colonies
No. inserts
No. differentially
expressed mRNAs
after screening
Truly differential
expressed fragments
Functional description
of identified fragments
272 187
202 153 74% 82%
26 44 13% 29%
16 30 8% 19%
Figure 1 Flow diagram showing the number of cDNA fragments processed
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among others the cytochrome C oxidase complex, ATPases and
the NADH reductase complex (Darnell et al, 1990), all known to
be potentially associated with the apoptotic process. Little is
known about the function of BC200, however, it has been shown
that BC200 is associated with polymerase III transcripts, which by
itself makes a variety of small stable RNAs including the small 5S
RNA of the ribosome (Kremerskothen et al, 1998). 
A second cluster consists of genes directly involved in the
cellular injury response (CIR) such as hMSH6, HSP90 and
MDM2. The hMSH6 is a part of the DNA mismatch repair system
and forms a complex with hMSH2 that recognizes and initiates
repair of DNA damage (Lage et al, 1999). In analogy of its role in
DNA mismatch repair, it has been shown that hMSH6 may also
play a role in the recognition of cDDP-DNA adducts (Fink et al,
1996) and therefore may play a role in the initiation of the CIR.
Another important player in the CIR is HSP90 (Itoh and Tashima,
1991). HSP90 gets induced by cDDP under conditions of severe
damage as was demonstrated in mice kidney cells with cDDP-
induced acute renal failure and degenerative changes in epithelial
cells (Satoh et al, 1994). Part of the function of HSP90 is to chap-
erone the folding of proteins and by doing so play a role in regu-
lating signal transduction pathways that control cell growth and
survival. A third member of this CIR cluster is the MDM2 gene, an
important player in the p53 pathway through the formation of a
MDM2–p53 auto-regulatory feedback loop (Oliner et al, 1993).
For several other identified cDNA fragments the role in the CIR is
less clear. The dead box protein gene DDX1 might be involved in
translation, RNA splicing and RNA stability, while the function of
NICE-5, JkA7, KIAA0017 and cDNA fragment are unknown. 
In the DOWN library 3 functional gene clusters could be identi-
fied, involving cell structure, signalling and protein translation.
The first cluster contains genes such as α -tubulin, β -actin, cytoker-
atin, actin-binding protein, keratin-related protein, cytokeratin 13,
and thymosin β 4. The changes in expression level of a number of
cytoskeletal components suggest a reorganization of the microfila-
ment system in response to the cDDP-induced injury which has
also been observed during the process of cell death (Brancolini
et al, 1997). Cells retract from adhesion substrate, sever the
contacts with neighbouring cells, and actin filaments will be
concentrated in the perinuclear area in a ring-like organization,
resulting in among others, the down-regulation of the actin-
binding protein and thymosin β 4, an actin-sequestering protein
(Huff et al, 1999) and the rupture of α -tubulin during the apoptotic
process (Kato, 1999). The function of the Wilm’s tumour-related
protein in human is unknown, however, its yeast homologue
GRC5, seems to be an essential yeast gene for the establishment of
a proper cytoskeletal structure (Koller et al, 1996). Summarizing,
the parallel down-regulation of the expression level of so many
cytoskeletal-related genes strongly suggests a well-orchestrated
process dismantling the structure of the cell. 
A second cluster contains a set of genes involved in various
signalling pathways. Transketolase and the thyroid hormone-
binding protein are both part of the metabolic energy pathways in
the cell. Transkelotase is part of the pentose phosphate pathway
(Pontremoli and Grazi 1968) and the thyroid hormone-binding
protein gene encodes a monomer of pyruvate kinase, which can
lead to decreased pyruvate kinase activity (Dieudonne et al, 1999).
Two other genes, ferritin H chain and transcription factor HSF4b,
are involved in pathways activated by oxidative stress or damage.
Ferritin synthesis plays a major role in the prevention of cellular
damage (Balla et al, 1992) while the transcription factor HSF4b
acts as a transcriptional activator of the heat-shock proteins
(Tanabe et al, 1999). This cluster also contains the interferon-
inducible gene family 1-8U. This gene is induced by both type 1
(α and β ) and type II (γ ) IFN. The function of IFN-inducible gene
1-8U remains, however, unclear. Taken this all together, it is clear
that the down-regulation of genes present in this cluster negatively
affects the cells’ energy metabolism and the ability to react on
stress. 
A third cluster in the DOWN library indicates that the protein
synthesis is reduced at several levels. First the expression levels of
elongation factors 1-alpha and 1-gamma, which are known to
Table 1 Truly differentially expressed fragments present in the UP library 
Clone number Fragment  GenBank  GenBank  Fold increase  Function 
identity identity accession # in expression
326 mitochondrion (2851–3089) HUMMTA D38112 13.7 Ribosomal products
230b mitochondrion (2849–3124) HUMMTA D38112 6.2 
119b mitochondrion (2332–2544) HUMMTA D38112 3.9 mtDNA coding for 16S rRNA 
313 mitochondrion (2282–2629) HUMMTA D38112 2.1 
46a BC200 HSBC200RNA U01305 2.1 Associated with 5S rRNA 
Genes involved in the CIR
83b hMSH6 HSU54777 U54777 3.5 DNA damage recognition and repair 
203b HSP90 HSHSP90R X15183 1.8 Early response gene, 
heat shock protein 
339 MDM2 F144014S16 AF144029 2.0 
336 MDM2 F144014S16 AF144029 1.9 
280 MDM2 F144014S16 AF144029 1.9 Negative feedback for p53
247 MDM2 F144014S16 AF144029 1.7 
Function unknown
165b DDX1 (dead box protein) HSCL1042 X70649 2.4 Translation, RNA splicing and 
RNA stability 
299 NICE-5 protein NM_017582 NM_017582 1.8 Part of human epidermal 
differentiation complex 
65b Human clone JkA7 mRNA HSU38436 U38436 1.7 unknown 
94b KIAA0017 HUMRSC399 D13642 4.1 unknown 
242 unknown 1.6 unknown 
}
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mediate the binding of aminoacyl-tRNAs to acceptor sites of ribo-
somes during protein synthesis (Duttaroy et al, 1998), are down-
regulated. Second, exposure to cDDP negatively affects the
synthesis as well as the number of active ribosomes as demon-
strated by the decrease in level of expression of several ribosomal
RNAs (Jordan and Carmo-Fonseca, 1998). Thirdly, the expression
level of the proteasome subunit HC3, a gene involved in protein
breakdown is reduced as well and may serve as a feedback reac-
tion on the reduced protein production (Tiao et al, 1997). For the
remaining genes the function is either unknown or not well under-
stood yet. 
In summary, the present study used a PCR-based subtraction
strategy to provide an analysis of the cellular injury response to
cDDP. The cytotoxic response to cDDP in UMSCC10b cells
involved the induction as well as the repression of genes. The
majority of these genes identified as differentially expressed
could be grouped in clusters based on their functional descrip-
tion. These clusters included genes involved in energy produc-
tion, response to damage, organization of the cytoskeleton,
protein synthesis and signalling transduction, providing a map
for an expression profile associated with the injury response to
cDDP, underlining the feasibility of using a molecular profile or
fingerprint of anticancer drugs in tumours as a prognostic tool. 
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